Behind the Curtain: How America’s Biggest Insurers Allegedly Rigged the Medicare Game
Picture an elderly neighbor, leafing through piles of confusing mailers each fall, trying to pick a Medicare plan amid promises of lower costs and better care. Now imagine that, unbeknownst to her, the very system designed to help seniors has been influenced by secret kickbacks—and that the odds were quietly stacked in favor of industry profits, not her health.
This isn’t the plot of a dark political thriller, but the latest real-world scandal ensnaring some of America’s largest health insurance companies. The U.S. Department of Justice alleges that industry titans—including Aetna (a CVS Health subsidiary), Elevance Health, and Humana—funneled hundreds of millions in illegal payments to brokers like Chicago-based GoHealth, eHealth, and SelectQuote. The goal? To funnel unsuspecting seniors into Medicare Advantage (MA) plans that maximize insurer revenue, even if those plans may not truly fit patient needs.
The Justice Department complaint, filed under the False Claims Act, outlines a scheme that ran from 2016 to 2021, spotlighting just how deep-rooted and systemic these practices may have become. According to prosecutors, brokers didn’t just receive routine commissions for connecting consumers to policies—they were allegedly incentivized beyond legal limits to push specific plans. These payments, allegedly disguised as legitimate marketing expenses, constitute what regulators call “illegal kickbacks.”
This isn’t just a technical regulatory breach: it strikes at the integrity of a system serving tens of millions of seniors and people with disabilities. As Harvard economist Mark Miller said in a recent interview, “Kickbacks warp incentives, and when those incentives govern healthcare choices, everyday Americans pay the price.”
Who Pays the Price? Seniors, Patients with Disabilities, and Public Trust
Beneath the legal language and corporate defenses lies a human cost. About 12% of Medicare beneficiaries are under 65 and qualify due to disability—a group that requires complex care and, not coincidentally, is described by the DOJ as viewed with suspicion by insurers for being less profitable. The complaint goes further, accusing Aetna and Humana of conspiring with brokers to discourage enrollment by these vulnerable patients as part of a broader pattern of discrimination.
Every time a broker nudges a beneficiary toward a plan for their own gain, patients risk losing access to crucial medications, specialists, or therapies best suited to their actual health needs. Medicare Advantage has long been dogged by criticism that its cost-cutting incentives can mean skimpier coverage or fewer provider choices, even as TV ads and glossy brochures promise otherwise.
“When big corporations prioritize profit over patients, it’s always the most vulnerable who suffer first. This is a stark reminder that our healthcare system needs strong oversight—not more backroom deals.”
What’s most disturbing isn’t just the scope—hundreds of millions allegedly paid out from 2016 through at least 2021—but the normalization of such pay-to-play arrangements. As medical ethicist Dr. Lisa Shah points out, “When incentives aren’t aligned with patient health or patient choice, bad outcomes follow. It becomes a matter of public policy and of public trust.”
Systemic Failures, Weak Oversight, and the Consequences of Deregulation
The Medicare Advantage program, launched in 2003 during the George W. Bush administration as a step toward privatizing parts of Medicare, was touted as a way to offer more ‘choice’ and flexibility. Instead, the past two decades have repeatedly exposed holes in oversight—from shady marketing practices to upcoding schemes—where companies chase profit at the expense of vulnerable citizens.
This latest scandal echoes broader failings seen when regulatory guardrails are weakened. Substantial campaign contributions from the healthcare industry often translate to lax enforcement and toothless fines; the cycle is corrosive to democracy itself. According to a recent Pew Research study, public trust in the nation’s health insurers has cratered, with only 33% expressing confidence these companies place patient welfare above profits.
Contrast this with other nations that keep strict controls over private health actors: Germany and France, for instance, require that all broker commissions remain transparent and capped, and violations carry meaningful penalties. The American model, left to market “self-regulation,” continues to invite abuses, as this DOJ case starkly demonstrates.
So what happens next? Federal prosecutors, spurred by whistleblowers, are signaling more aggressive action—and the public is watching closely. The threat of substantial civil penalties and possible criminal sanctions means the stakes are higher than any simple regulatory fine.
What larger lesson should Americans draw from this moment? At its core, the scandal highlights why progressive voices have long called for robust consumer protections, greater transparency, and an end to profit-driven abuses in healthcare. As calls grow for Medicare-for-All and other public options, episodes like this underscore that universal coverage can’t mean more sweetheart deals for the few. Instead, healthcare must be built around human dignity, public accountability, and equity for all.
